Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Chemotherapy-Induced Nausea and Vomiting Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Supply by Company

    • 2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Company
    • 2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Company
    • 2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Company
    • 2.4 Chemotherapy-Induced Nausea and Vomiting Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by Category

    • 3.1 Chemotherapy-Induced Nausea and Vomiting Drugs Category Introduction
      • 3.1.1 Existing Drugs
      • 3.1.2 Akynzeo (Netupitant-Palonosetron FDC)
      • 3.1.3 Aloxi (Palonosetron)
      • 3.1.4 Emend (Aprepitant)
      • 3.1.5 Kytril Generic (Granisetron)
      • 3.1.6 Zofran Generic (Ondansetron)
      • 3.1.7 Pipeline Drugs
      • 3.1.8 SUSTOL (Granisetron Injection extended release)
      • 3.1.9 Rolapitant
    • 3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Category
      • 3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Category (2016-2021)
      • 3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Category (2016-2021)
      • 3.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by End User/Segment

    • 4.1 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by End User/Segment
      • 4.1.1 Serotonin Receptor Antagonists
      • 4.1.2 NK1 Receptor Antagonists
    • 4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by End User/Segment
      • 4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by Region

    • 5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region
      • 5.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Region
      • 5.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Region
    • 5.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Status
    • 5.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Status
    • 5.4 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Status
    • 5.5 Central & South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Status
    • 5.6 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Status

    6 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Status

    • 6.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market by Country
      • 6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Country (2016-2021)
      • 6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Status

    • 7.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market by Country
      • 7.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Status

    • 8.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market by Country
      • 8.1.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Status

    • 9.1 Central & South America Chemotherapy-Induced Nausea and Vomiting Drugs Market by Country
      • 9.1.1 Central & South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Status

    • 10.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market by Country
      • 10.1.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
    • 11.5 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channel
      • 11.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
    • 11.6 Chemotherapy-Induced Nausea and Vomiting Drugs Downstream Major Buyers

    12 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecast by Category
      • 12.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by Category
      • 12.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value Forecast by Category
      • 12.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Category
    • 12.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecast by End User/Segment
      • 12.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value Forecast by End User/Segment
      • 12.3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by End User/Segment

    13 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Region/Country

    • 13.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Region (2022-2027)
      • 13.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Tesaro, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.1.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sun Pharmaceutical Industry Ltd.
      • 14.2.1 Company Information
      • 14.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.2.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Otsuka Holdings Co., Ltd.
      • 14.3.1 Company Information
      • 14.3.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.3.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Merck & Co., Inc.
      • 14.4.1 Company Information
      • 14.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.4.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Heron Therapeutics, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.5.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Helsinn Group
      • 14.6.1 Company Information
      • 14.6.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.6.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 GlaxoSmithKline plc
      • 14.7.1 Company Information
      • 14.7.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.7.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 F. Hoffmann-La Roche Ltd.
      • 14.8.1 Company Information
      • 14.8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.8.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Dr. Reddy's Laboratories Ltd.
      • 14.9.1 Company Information
      • 14.9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.9.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Acacia Pharma
      • 14.10.1 Company Information
      • 14.10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
      • 14.10.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Chemotherapy-Induced Nausea and Vomiting Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Chemotherapy-Induced Nausea and Vomiting Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Existing Drugs
      Akynzeo (Netupitant-Palonosetron FDC)
      Aloxi (Palonosetron)
      Emend (Aprepitant)
      Kytril Generic (Granisetron)
      Zofran Generic (Ondansetron)
      Pipeline Drugs
      SUSTOL (Granisetron Injection extended release)
      Rolapitant

      Segmented by End User/Segment
      Serotonin Receptor Antagonists
      NK1 Receptor Antagonists

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Tesaro, Inc.
      Sun Pharmaceutical Industry Ltd.
      Otsuka Holdings Co., Ltd.
      Merck & Co., Inc.
      Heron Therapeutics, Inc.
      Helsinn Group
      GlaxoSmithKline plc
      F. Hoffmann-La Roche Ltd.
      Dr. Reddy's Laboratories Ltd.
      Acacia Pharma
      Buy now